Ascend Advanced Therapies

Ascend Advanced Therapies, formed from the merger of Ascend and ABL, combines 60 years of experience to deliver one of the industry's most comprehensive viral vector manufacturing capabilities. We specialize in GMP production of viruses for cell and gene therapy, oncolytic virus therapy, and vaccines across platforms and scales. Our collaborative CMC approach guides clients from clinic to commercialization, aiming to balance yield and quality in life-saving therapies.